Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eric J. Lentsch is active.

Publication


Featured researches published by Eric J. Lentsch.


Laryngoscope | 2012

Merkel cell carcinoma: Identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data†‡

Valerie A. Smith; E. Ramsay Camp; Eric J. Lentsch

Merkel cell carcinoma (MCC) is an aggressive cutaneous neoplasm that occurs most frequently in the head and neck region. Because of its rarity, prognostic factors are poorly characterized. Head and neck MCC (HN‐MCC) may require separate consideration from MCC that occurs in other anatomic regions. Our objective was to determine the relevance of clinicopathologic parameters as prognostic factors in a large series of patients with HN‐MCC and to compare these to a series of patients with non–head and neck MCC (NHN‐MCC).


Journal of Surgical Oncology | 2012

Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database.

Valerie A. Smith; Roy B. Sessions; Eric J. Lentsch

Determine how the location of cervical lymph node metastases affects survival in papillary thyroid carcinoma (PTC) patients.


Otolaryngology-Head and Neck Surgery | 2006

Toxic metabolic encephalopathy after parathyroidectomy with methylene blue localization

Swapna S. Kartha; Chris E. Chacko; Jeffrey M. Bumpous; Muffin M. Fleming; Eric J. Lentsch; Michael B. Flynn

OBJECTIVE: To determine the correlation between methylene blue use and toxic metabolic encephalopathy in patients undergoing surgery for primary hyperparathyroidism. STUDY DESIGN AND SETTING: A retrospective study of 193 patients was performed to collect demographic, perioperative, and postoperative data. Patients were divided into two groups: Group A (postoperative neurological sequelae) and Group B (no neurological sequelae). All data points were compared between the groups. RESULTS: Twelve of 193 patients were placed in Group A; 181 patients were placed in Group B. Ten patients in Group A were female, and 10 patients were older than 60 years. Of the patients in Group A, 100% were taking a serotonin reuptake inhibitor (SRI). In Group B, 8.8% of patients were taking an SRI. CONCLUSION: All the patients who experienced transient neurological events were taking an SRI. A correlation can be made between methylene blue infusion and SRI usage. SIGNIFICANCE: Patients taking SRIs may represent a high-risk group for postoperative neurological events when methylene blue is utilized.


Laryngoscope | 2011

Thyroid disease and compressive symptoms

Caroline A. Banks; Christopher M. Ayers; Joshua D. Hornig; Eric J. Lentsch; Terry A. Day; Shaun A. Nguyen; M. Boyd Gillespie

Compressive symptoms are common in thyroid disease, but few studies have focused on the presence, associated factors, and etiology of compressive symptoms.


Otolaryngology-Head and Neck Surgery | 2012

Reevaluating the prognostic significance of age in differentiated thyroid cancer.

Samuel L. Oyer; Valerie A. Smith; Eric J. Lentsch

Objective To determine the impact of age on disease-specific survival in differentiated thyroid cancer. Study Design Retrospective analysis of a large population database. Setting Surveillance, Epidemiology, and End Results (SEER) database/multiple settings. Subjects and Methods The SEER database was examined to identify patients diagnosed with either papillary or follicular carcinoma of the thyroid between the years 1988 and 2003. Information obtained included patient age, sex, tumor type, size, extension, and nodal or distant metastases. Kaplan-Meier survival analyses were used to estimate disease-specific survival based on patient age range, and the log-rank test was used to assess for statistical differences between survival curves. A multivariate analysis was performed including the variables listed above to determine disease-specific hazard ratios of death for various age cutoffs. Results A total of 42,209 patients were identified. Patients 45 years and older had significantly worse survival than younger patients (P < .0001). A significant decrease in disease-specific survival was first seen in patients aged 35 years and older, and survival continued to steadily decrease with each additional decade of age (P < .001). Patients aged 35 years and older were 14 times more likely to die from differentiated thyroid cancer than patients younger than 35 years. Conclusion Increasing age is associated with poorer survival in differentiated thyroid cancer. This relationship represents a continuum with an initial decrease in survival starting at age 35 years that continues to decline with further advancing age.


Laryngoscope | 2006

Microvessel Density in Head and Neck Squamous Cell Carcinoma Primary Tumors and Its Correlation with Clinical Staging Parameters

Eric J. Lentsch; Steven Goudy; Jeffrey Sosnowski; Scott Major; Jeffrey M. Bumpous

Objective: Our objective was to assess angiogenesis in head and neck squamous cell primary tumors and measure its correlation with tumor site and clinical and pathologic staging parameters.


Annals of Plastic Surgery | 2004

Incidence of nonlocalization of sentinel lymph nodes using preoperative lymphoscintigraphy in 74 consecutive head and neck melanoma and Merkel cell carcinoma patients.

Wayne K. Stadelmann; Lorri Cobbins; Eric J. Lentsch

Introduction:Lymphatic drainage pathways in the head and neck region are more variable than in any other location of the body. Occasionally, head and neck lymphoscintograms fail to identify a definitive lymphatic drainage pattern, making preoperative and intraoperative identification of sentinel nodes very difficult. The purpose of this study was to determine the incidence of nonlocalization on lymphoscintigraphy of sentinel nodes in patients with head and neck cutaneous malignancies. Methods:A retrospective chart review was conducted of a single surgeons (WKS) 135 consecutive head and neck melanoma and Merkel cell cancer patients from August 1997 to August 2002. In all cases. technetium-99m sulfur colloid was the radioactive tracer used by the nuclear medicine department to perform the lymphoscintograms. Results:Of the 135 patients, 74 underwent preoperative lymphoscintigraphy in preparation for performing a sentinel lymph node biopsy. Of these 74 patients, 5 (6.8%) were found to have nonlocalization of a sentinel node(s). Of the 5 patients who failed to localize, 3 had primary lesions near the midline scalp, while 2 had primary lesions located on the cheek. Two of the 5 patients underwent reinjection of the radioisotope by the treating surgeon (WKS) but failed to further localize the radiotracer. All 5 patients went on to have wide local excision of the primary cancer on the day of the lymphoscintogram, as well as undergoing intraoperative examination of all head and neck nodal basins with a handheld &ggr; detector. No focal areas of radiation were identified and no lymph nodes were biopsied. To date, 1 patient has developed distant metastases and has succumbed to her disease. The remaining 4 patients are free of disease. Conclusion:In a series of 135 consecutive patients with head and neck cutaneous malignancies, 74 of whom were treated with preoperative lymphoscintograms, a nonlocalization rate of 6.8% was found. This is a significant rate of nonlocalization and reflects either the inherent difficulty in imaging the head and neck region and/or the possible rapid rate of dye washout via multiple lymphatic drainage pathways that exist in this location.


International Journal of Pediatric Otorhinolaryngology | 2000

Rate of persistent perforation after elective tympanostomy tube removal in pediatric patients.

Eric J. Lentsch; Steve Goudy; Toni M. Ganzel; Julie L. Goldman; Alan J. Nissen

This study was performed to determine the rate of persistent perforations according to age, tube type and duration of intubation in children who underwent elective tympanostomy tube removal. Our retrospective analysis of hospital and clinic charts included all patients who underwent elective tube removal from July 1995 to December 1997 at our institution. Information from the chart review included patient age at time of tube removal, type of tube removed, duration of intubation, presence of granulation tissue/polyps, and concomitant paper patch placement. The outcome of each surgical removal was determined by examining follow-up clinic charts. A patient was deemed to have a persistent perforation if the eardrum had not adequately healed within 3 months after surgery. Data on 201 patients were gathered. These patients had 273 tube removals. Eleven percent of ears (29/273) had persistent perforations. According to tube type, no perforations (0/48) occurred with Collar Bobbin tubes, 6% (3/50) with Tytan tubes, 7% (3/44) with Duravent tubes, and 22% (16/74) with Paparella II tubes. Three percent (3/101) of tubes in place for <3 years and 15% (26/172) of tubes in place for >3 years showed persistent perforations after removal. Ears with granulation polyps had a 9% (18/203) rate of perforations, whereas those without granulation polyps had a 16% (11/70) rate of perforations. Forty percent (4/10) of ears were treated with paper patches at the time of tube removal showed persistent perforations. Our data indicate that the rate of persistent perforation (11%) after elective tympanostomy tube removal is high. The factors associated with higher rates of persistent perforation (P<0.05) include duration of intubation >3 years prior to removal and the use of long-term Paparella II tubes.


Annals of Otology, Rhinology, and Laryngology | 2014

Spindle Cell Carcinoma of the Upper Aerodigestive Tract An Analysis of 341 Cases With Comparison to Conventional Squamous Cell Carcinoma

Daniel Gerry; Valerie A. Fritsch; Eric J. Lentsch

Objectives: We sought to better characterize spindle cell carcinoma (SpCC) of the upper aerodigestive tract, a rare and aggressive variant, through comparison of a large cohort of head and neck SpCCs against a cohort of conventional head and neck squamous cell carcinoma (SCC) patients. Methods: We compared epidemiologic and clinicopathologic characteristics of 341 SpCCs with 67 882 SCCs of the head and neck, drawing data from the SEER national database. We also compared disease-specific survivals (DSS) for SpCC and SCC based on tumor site and mode of treatment. Results: SpCCs were predominantly laryngeal (46.4%, P < .001) and were more likely to be high grade (P > .001). SpCCs were also more likely than SCCs to present at an early stage (P < .001 to P < .05). Rates of distant metastasis were similar between the tumor types. DSS was similar between SpCCs and SCCs, although site-specific survival rates were higher for SpCCs of the larynx (P = .017) and lower for those of the oral cavity (P = .008). Conclusion: SpCC of the head and neck is more likely than SCC to present at an early stage, with fewer nodal metastases. Survival rates appear to depend on anatomic site as well.


Otolaryngology-Head and Neck Surgery | 2010

Minimally invasive video-assisted thyroidectomy versus conventional thyroidectomy: A cost-effective analysis

J. Kenneth Byrd; Shaun A. Nguyen; Amy S. Ketcham; Joshua D. Hornig; M. Boyd Gillespie; Eric J. Lentsch

OBJECTIVE: To compare the cost of minimally invasive video-assisted thyroidectomy (MIVAT) with conventional thyroidectomy. STUDY DESIGN: A cost-effectiveness study and chart review. SETTING: Academic university hospital. SUBJECTS AND METHODS: Pediatric and adult patients referred to the Department of Otolaryngology-Head and Neck Surgery for suspicious thyroid nodules, goiters, or known carcinomas. A tertiary care hospitals billing department was queried for all hemithyroidectomies and total thyroidectomies completed by the Department of Otolaryngology- Head and Neck Surgery between January 5, 2006, and November 1, 2007. The charges, including surgery, hospital, pathology, and anesthesia, for minimally invasive video-assisted thyroidectomy (MIVAT) and traditional or minimally invasive open thyroidectomies meeting MIVAT inclusion criteria were then reviewed retrospectively and compared statistically. RESULTS: A total of 185 thyroidectomies were performed, 50.3 percent of which met criteria for MIVAT. Length of stay (days) was significantly shorter for patients undergoing MIVAT hemithyroidectomy (mean difference −0.8; 95% confidence interval [95% CI] −1.08 to −0.52) and not significantly different between groups for total thyroidectomy (mean difference 0.1; 95% CI −0.36 to 0.56). Mean anesthesia cost (U.S.

Collaboration


Dive into the Eric J. Lentsch's collaboration.

Top Co-Authors

Avatar

Shaun A. Nguyen

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Valerie A. Fritsch

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kevin Y. Zhan

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Terry A. Day

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

David M. Neskey

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

Joshua D. Hornig

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

William A. Stokes

Medical University of South Carolina

View shared research outputs
Top Co-Authors

Avatar

M. Boyd Gillespie

University of Tennessee Health Science Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge